Aging is marked by complex physiological changes that contribute to functional decline and increased vulnerability to disease. In a review published in the Korean Journal of Family Medicine, researchers examine the potential of allogeneic stem cells—derived from sources such as umbilical cord tissue, placenta, and cord blood—to address these aging-related mechanisms.
According to the review, umbilical cord-derived mesenchymal stem cells (MSCs) are of particular interest due to their low immunogenicity and strong immunomodulatory properties. These cells have demonstrated the potential to secrete biologically active molecules—such as cytokines, growth factors, and exosomes—that contribute to tissue repair and enhanced metabolic and cognitive functions.
Preclinical and clinical findings now suggest that allogeneic stem cells may help alleviate osteoporosis, osteoarthritis, cardiovascular diseases, and neurodegenerative conditions.
This review highlights how the biological mechanisms of allogeneic stem cells may contribute to strategies aimed at delaying systemic aging and potentially extending a healthy lifespan.
